Loading clinical trials...
Loading clinical trials...
Immunotherapy has become the major breakthrough and the most promising treatment, with the host of development of tumor biology, molecular biology and immunology. We have developed anti-ROBO1 CAR-NK c...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Asclepius Technology Company Group (Suzhou) Co., Ltd.
NCT07042100 · Advanced Solid Tumors
NCT07589530 · Advanced Solid Tumors, Metastatic Solid Tumors, and more
NCT06659341 · Advanced Solid Tumors Harboring KRAS G12C Mutation
NCT07087197 · Metastatic Solid Tumors
NCT07300150 · Colorectal Cancer, Pancreatic Cancer, and more
Radiation Therapy Department, Suzhou Cancer Center, Suzhou Hospital Affiliated to Nanjing Medical University
Suzhou, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions